How do short-acting β₂-agonists such as albuterol relieve bronchospasm?
Short-Acting β₂-Agonists Online Quiz Questions
Use this free practice quiz with 20 questions to review Short-Acting β₂-Agonists, test your knowledge, and prepare for your next test or exam.
Select all statements about short-acting β₂-agonists that are correct.
- A
They are inhaled by pMDI, preferably with a spacer, or by nebulizer.
- B
They are routinely given as oral tablets because inhaled delivery is ineffective.
- C
Tremor, nervousness, palpitations, and tachycardia are common dose-related effects.
- D
With frequent or high-dose treatment, assess heart rate and consider ECG and potassium; consider lactate if unexplained acidosis or persistent tachypnea occurs.
- E
Repeated high doses increase serum potassium and reliably prevent arrhythmias.
Short-acting β₂-agonists are first-line reliever bronchodilators in acute asthma and are also initial bronchodilators in COPD exacerbations.
- A
True
- B
False
Name one short-acting β₂-agonist listed as an example.
Short-acting β₂-agonists stimulate receptors in airway smooth muscle, increasing and relaxing the muscle.
Explain how short-acting β₂-agonists work and are used in acute asthma and COPD exacerbations. Include their administration, important adverse effects, and monitoring.
A patient experiencing an acute exacerbation cannot use an inhaler effectively. Which inhaled delivery method may be useful for a short-acting β₂-agonist?
- A
Switch to an oral β₂-agonist, because inhaled treatment cannot relieve acute bronchospasm.
- B
Use a nebulizer, which may be useful when the patient cannot use an inhaler effectively.
- C
Use a long-acting bronchodilator as the initial rescue treatment.
- D
Use intravenous magnesium sulfate routinely for every exacerbation.
Select all appropriate monitoring considerations for a patient receiving a short-acting β₂-agonist during an acute exacerbation.
- A
Monitor symptom relief, respiratory rate, work of breathing, and oxygen saturation.
- B
Use ECG and potassium testing as mandatory routine monitoring for every patient receiving any dose.
- C
When feasible, monitor PEF or FEV₁.
- D
With frequent or high-dose therapy, assess heart rate and consider ECG and potassium; consider lactate if unexplained acidosis or persistent tachypnea occurs.
- E
Monitor only for urinary retention and eye pain.
Repeated high doses of short-acting β₂-agonists can lower serum potassium, and high-dose treatment can raise lactate.
- A
True
- B
False
Which serum electrolyte can be lowered by repeated high doses of short-acting β₂-agonists?
stimulate β₂-adrenergic receptors in airway smooth muscle and increase cyclic AMP.
How do short-acting β₂-agonists act to relieve bronchospasm?
- A
They block muscarinic receptors and reduce airway secretions.
- B
They stimulate β₂-adrenergic receptors, increase cyclic AMP, and relax airway smooth muscle.
- C
They activate glucocorticoid receptors and suppress airway inflammation.
- D
They block β₂-adrenergic receptors and tighten airway smooth muscle.
True or false: Repeated high doses of short-acting β₂-agonists can lower serum potassium.
- A
True
- B
False
Which inhaled device may be useful when a patient cannot use an inhaler effectively?
A patient with an acute COPD exacerbation cannot use an inhaler effectively. Which inhaled delivery approach is supported for a short-acting β₂-agonist?
- A
Use a nebulizer when the patient cannot use an inhaler effectively.
- B
Use an oral tablet because inhaled delivery is not recommended.
- C
Use a long-acting bronchodilator as the initial rescue treatment.
- D
Avoid a spacer because it prevents rapid inhaled delivery.
Which common dose-related adverse effect of short-acting β₂-agonists is an abnormally fast heart rate?
For a patient receiving frequent or high-dose short-acting β₂-agonist therapy, which additional monitoring is supported?
- A
Monitor only blood glucose and mood.
- B
Monitor urinary symptoms and eye pain.
- C
Assess heart rate and consider ECG and serum potassium.
- D
Monitor reflexes and blood pressure as the specific routine for β₂-agonists.
Which statement best describes the role of short-acting β₂-agonists in acute asthma and COPD exacerbations?
- A
They are maintenance-only drugs and are not used as initial bronchodilators in COPD exacerbations.
- B
They rapidly relieve bronchospasm, are first-line relievers in acute asthma, and are initial bronchodilators in COPD exacerbations.
- C
They work primarily by suppressing airway inflammation, with delayed benefit.
- D
They must be used alone and cannot be combined with systemic corticosteroids when indicated.
How do short-acting β₂-agonists such as albuterol produce bronchodilation?
- A
They block muscarinic receptors, reducing vagal bronchoconstriction.
- B
They stimulate β₂-adrenergic receptors, increasing cyclic AMP and relaxing airway smooth muscle.
- C
They activate glucocorticoid receptors and suppress airway inflammation.
- D
They inhibit airway secretions by blocking histamine receptors.
A patient with an acute asthma exacerbation cannot use an inhaler effectively. Which approach is supported for delivering a short-acting β₂-agonist?
- A
Use an oral β₂-agonist because inhaled delivery is unsuitable during an exacerbation.
- B
Use a long-acting bronchodilator as the initial rescue treatment.
- C
Consider a nebulizer if the patient cannot use an inhaler effectively.
- D
Avoid bronchodilators until the patient can perform peak flow measurements.
Related study packs and tools
- Quiz
1 EMS Systems and Operations
A medium-difficulty quiz on EMS systems, clinician roles, medical direction, communications, and coordination among response partners.
NREMT Paramedic OperationsUpdated - Study guide
1 Scene Assessment and Emergency Priorities
Learn how to make an emergency scene safer, rapidly identify and address immediate threats to life, prioritize patients, and reassess as conditions change.
- Study guide
2 Immediate Stabilization Decisions
A practical guide to recognizing immediate threats, providing appropriate first aid while EMS is coming, and prioritizing emergency transport decisions.
- Flashcards
2 Mechanism of Injury and Nature of Illness
Learn how to assess scene safety, identify the mechanism of injury or nature of illness, and use findings to anticipate patient care and resource needs.
- Study guide
3 Hazardous Materials Awareness for EMS
Learn how awareness-level EMS responders recognize possible hazardous-materials releases, stay safe, communicate with incident command, and coordinate patient care without exceeding their role.
NREMT Paramedic OperationsUpdated - Quiz
4 Destination Decisions and Transport Planning
A medium-difficulty quiz on selecting and communicating an appropriate patient destination using patient needs, facility capabilities, travel conditions, and local protocols.
- Study guide
4 Destination Decisions and Transport Planning
Learn how to select and communicate a patient destination by matching clinical risk and likely care needs to facility capability, travel conditions, and local EMS protocols.
- Study guide
4 Patient Transport and Ambulance Operations
Learn how EMS teams move and secure patients, operate ambulances safely, choose destinations, and coordinate ground or air transport.
NREMT Paramedic OperationsUpdated - Study guide
4 Prioritize Hypotheses
Learn how to compare plausible explanations for a client’s findings and prioritize the concern that poses the greatest immediate risk.
- Quiz
5 Generate Solutions
A medium-difficulty quiz on setting measurable patient goals and selecting, implementing, and evaluating interventions that address the priority problem.
- Study guide
6 Take Action
Learn how to implement safe, prioritized nursing interventions, respond to deterioration, communicate concerns, and reassess patient outcomes.
- Quiz
8 Integrated NGN Case Studies
Practice applying the NGN clinical judgment steps, using common item formats, and interpreting client changes.